Management of the prosthetic vascular graft infections - The influence of predictive factors on treatment results

Bratislava Medical Journal

Volumn 109, Issue 12, 2008, Pages 544-550

  Treska, V ^a   Houdek, K ^a   Vachtova, M ^a   Smid, D ^a   Kormuda, S ^b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Ggraft patency; Morbidity; Mortality; Predictive factors; Prosthetic vascular graft infection

Indexed keywords

C REACTIVE PROTEIN;

AGED; ARTICLE; BLOOD; BLOOD VESSEL PROSTHESIS; DEVICE REMOVAL; FEMALE; HUMAN; INFECTION; LEUKOCYTE COUNT; MALE; MIDDLE AGED; PROGNOSIS; REOPERATION;

AGED; BLOOD VESSEL PROSTHESIS; C-REACTIVE PROTEIN; DEVICE REMOVAL; FEMALE; HUMANS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; PROGNOSIS; PROSTHESIS-RELATED INFECTIONS; REOPERATION;

EID: 62549136531     PISSN: 00069248     EISSN: 13360345     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Shahidi S, Eskil A, Lundof E, Klaerke A, Jensen BS. Detection of abdominal aortic graft infection: comparison of magnetic resonance imaging and indium-labeled white blood cell scanning. Ann Vasc Surg 2007; 21: 586-592.
2. Homer-Vanniasinkam S. Surgical site and vascular infections: treatment and prophylaxis. Int J Infect Dis 2007; 11 Suppl 1: S17-22.
3. Amstrong PA, Back MR, Bandyk DF, Johnson BL, Shames ML. Selective application of sartorius flaps and aggressive staged surgical debridement can influence long-term outcomes of complex prosthetic. graft infections. J Vasc Surg 2007; 46: 71-78.
4. Szylagyi DE, Smith RF, Elliott JP, Vrandecic MP. Infection of arterial reconstruction with synthetic grafts. Ann Surg 1972; 176: 321-333.
5. Bunt TJ. Synthetic vascular graft infections. Surgery 1983; 93: 733-746.
6. Samson RH, Veith FJ, Janko GS, Gupta SK, Scher LA. A modified classification and approach to the management of infections involving peripheral arterial prosthetic grafts. J Vasc Surg 1988; 8: 147-153.
7. Bandyk DF. Aortic graft infection. Sem Vasc Surg 1990; 3: 122-134.
8. Goeau-Brissonniére O. Infection from arterial prostheses. Presse Med 1995; 24: 454-458.
9. Chiesa R, Astore D, Frigerio S. Vascular prosthetic graft infection: Epidemiology, bacteriology,pathogenesis and treatment. Acta Chir Belg 2002; 102: 238-247.
10. Bunt TJ. Vascular graft infections: an update. Cardiovasc Surg 2001; 9: 225-233.
11. Valentine RJ, Clagett GP. Aortic graft infections: Replacement with autogenous vein.Cardiovasc Surg 2001; 9: 419-425.
12. Chambers ST. Diagnosis and management of staphylococcal infections of vascular grafts and stents. Int Med J 2005; 35: S72-S78.
13. Orton DF, LeVeeu RF, Saigh JA. Aortic prosthetic graft infections: Radiologic manifestations and implications for management. RadioGraphics 2000; 20: 977-993.
14. Egun A, O'Neill H, Ward AS. Intragraft thrombus: An early CT finding in aortic graft infection. Eur J Vasc Endovasc Surg 2000; 20: 482-483.
15. Castelli P, Caronno R, Ferrarese S. New trends in prosthesis infection in cardiovascular surgery. Surg Infect 2006; 7 (Suppl 2): S45-S47.
16. Lauwers P, Van den Broeck S, Carp L, Hendriks J, Schil PV, Blockx P. The use of positron emission tomography with (18) F-fluoro-deoxyglucose for the diagnosis of vascular graft infection. Angiology 2008; 58: 717-724.
17. Oderich GS, Bower TC, Cherry KJ. Evolution from axillofemoral to in situ prosthetic reconstruction for the treatment of aortic graft infections at a single center. J Vasc Surg 2006; 43: 1166-1174.
18. O'Connor S, Andrew P, Batt M. A systematic review and meta-analysis of treatments for aortic graft infection. J Vasc Surg 2006; 44: 38-45.
19. Sigala F, Menenakos C, Baunach C. Inguinal anastomotic aneurysm due to salmonellosis treated with orthotopic reconstruction. Vasa 2006; 35: 37-40.
20. Zhou W, Lin PH, Bush RL. In situ reconstruction with cryopreserved arterial allografts for management of mycotic aneurysms or aortic prosthetic graft infections: a multi-institutional experience. Tex Heart Inst J 2006; 33: 14-18.
21. Schmacht D, Armstrong P, Johnsou B. Graft infectivity of rifampin and silver-bonded polyester grafts to MRSA contamination. Vasc Endovasc Surg 2005; 39: 411-420.
22. Ueberrueck T, Meyer L, Zippel R. Healing characteristics of a new silver-coated, gelatine impregnated vascular prosthesis in the porcine model. Zbl Chir 2005; 130: 71-76.
23. Ricco JB, InterGard Silver Study Group. InterGard silver bifurcated graft: features and results of a multicenter clinical study. J Vasc Surg 2006; 44: 339-346.
24. Gabriel M, Pukacki F, Checinski P. Current options in prosthetic vascular graft infection: comparative analysis of 63 consecutive cases. Langenbecks Arch Surg 2004; 389: 272-277.
25. Terpling S, Schade LC, Schouheyder HC. Long-term home-based parenteral antibiotic treatment of a prosthetic vascular graft infection caused by Pseudomonas aeruginosa. Scand J Infect Dis 2004; 38: 388-392.
26. Stone PA, Armstrong PA, Bandyk DF. Use of antibiotic-loaded polymethylmethacrylate beads for the treatment of extracavitary prosthetic vascular graft infections. J Vasc Surg 2006; 44: 757-761.
27. Kieffer E, Gomes D, Chiche L. Allograft replacement for infrarenal aorftic graft infection: early and late results in 179 patients. J Vasc Surg 2004; 39: 1009-1017.
28. Batt M, Magne JL, Alric P. In situ revascularization with silver-coated, polyester grafts to treat aortic infection: early and midterm results. J Vasc Surg 2003; 38: 988-989.
29. Perera GB, Fujitani RM, Kubaska SM. Aortic Graft Infection: Update on Management and Treatment Options. Vasc Endovasc Surg 2006; 40: 1-10.
30. Mussa FF, Hedayati N, Zhou W, El-Sayed HF, Kougias P, Darouiche RO, Lin H. Prevention and treatment of aortic graft infection. Expert Rev Anti Infect Ther 2007; 5: 305-315.